ENOVIS CORP (ENOV) Stock Fundamental Analysis

NYSE:ENOV • US1940141062

25.47 USD
+0.05 (+0.2%)
At close: Feb 27, 2026
25.47 USD
0 (0%)
After Hours: 2/27/2026, 8:04:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

4

Overall ENOV gets a fundamental rating of 4 out of 10. We evaluated ENOV against 185 industry peers in the Health Care Equipment & Supplies industry. ENOV may be in some trouble as it scores bad on both profitability and health. ENOV may be a bit undervalued, certainly considering the very reasonable score on growth


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • In the past year ENOV was profitable.
  • ENOV had a positive operating cash flow in the past year.
  • In the past 5 years ENOV reported 4 times negative net income.
  • Of the past 5 years ENOV 4 years had a positive operating cash flow.
ENOV Yearly Net Income VS EBIT VS OCF VS FCFENOV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -500M -1B

1.2 Ratios

  • ENOV has a Return On Assets (-30.84%) which is comparable to the rest of the industry.
  • ENOV has a Return On Equity (-67.66%) which is comparable to the rest of the industry.
  • ENOV's Return On Invested Capital of 0.12% is fine compared to the rest of the industry. ENOV outperforms 64.32% of its industry peers.
Industry RankSector Rank
ROA -30.84%
ROE -67.66%
ROIC 0.12%
ROA(3y)-6.18%
ROA(5y)-3.42%
ROE(3y)-11.19%
ROE(5y)-6.16%
ROIC(3y)N/A
ROIC(5y)N/A
ENOV Yearly ROA, ROE, ROICENOV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -20 -40 -60

1.3 Margins

  • ENOV's Operating Margin of 0.25% is fine compared to the rest of the industry. ENOV outperforms 64.32% of its industry peers.
  • ENOV's Operating Margin has declined in the last couple of years.
  • ENOV has a Gross Margin (57.19%) which is in line with its industry peers.
  • In the last couple of years the Gross Margin of ENOV has grown nicely.
Industry RankSector Rank
OM 0.25%
PM (TTM) N/A
GM 57.19%
OM growth 3YN/A
OM growth 5Y-43.59%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.41%
GM growth 5Y6.07%
ENOV Yearly Profit, Operating, Gross MarginsENOV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 -40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • ENOV has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • ENOV has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for ENOV has been increased compared to 5 years ago.
  • ENOV has a worse debt/assets ratio than last year.
ENOV Yearly Shares OutstandingENOV Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
ENOV Yearly Total Debt VS Total AssetsENOV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

2.2 Solvency

  • ENOV has an Altman-Z score of 0.76. This is a bad value and indicates that ENOV is not financially healthy and even has some risk of bankruptcy.
  • ENOV's Altman-Z score of 0.76 is in line compared to the rest of the industry. ENOV outperforms 49.73% of its industry peers.
  • ENOV has a debt to FCF ratio of 59.72. This is a negative value and a sign of low solvency as ENOV would need 59.72 years to pay back of all of its debts.
  • ENOV has a Debt to FCF ratio of 59.72. This is in the better half of the industry: ENOV outperforms 67.03% of its industry peers.
  • ENOV has a Debt/Equity ratio of 0.66. This is a neutral value indicating ENOV is somewhat dependend on debt financing.
  • The Debt to Equity ratio of ENOV (0.66) is worse than 65.95% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.66
Debt/FCF 59.72
Altman-Z 0.76
ROIC/WACC0.01
WACC9.63%
ENOV Yearly LT Debt VS Equity VS FCFENOV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B 4B

2.3 Liquidity

  • A Current Ratio of 2.22 indicates that ENOV has no problem at all paying its short term obligations.
  • ENOV has a Current ratio (2.22) which is comparable to the rest of the industry.
  • A Quick Ratio of 1.16 indicates that ENOV should not have too much problems paying its short term obligations.
  • ENOV has a Quick ratio of 1.16. This is in the lower half of the industry: ENOV underperforms 70.27% of its industry peers.
Industry RankSector Rank
Current Ratio 2.22
Quick Ratio 1.16
ENOV Yearly Current Assets VS Current LiabilitesENOV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an nice 16.61% over the past year.
  • Measured over the past years, ENOV shows a decrease in Earnings Per Share. The EPS has been decreasing by -4.57% on average per year.
EPS 1Y (TTM)16.61%
EPS 3Y13.28%
EPS 5Y-4.57%
EPS Q2Q%-3.06%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%2.64%

3.2 Future

  • ENOV is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 25.47% yearly.
  • ENOV is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.39% yearly.
EPS Next Y6.03%
EPS Next 2Y9.23%
EPS Next 3Y25.47%
EPS Next 5YN/A
Revenue Next Year4.69%
Revenue Next 2Y5.37%
Revenue Next 3Y9.39%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ENOV Yearly Revenue VS EstimatesENOV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B 4B
ENOV Yearly EPS VS EstimatesENOV Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

8

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 7.72, the valuation of ENOV can be described as very cheap.
  • Based on the Price/Earnings ratio, ENOV is valued cheaper than 98.38% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of ENOV to the average of the S&P500 Index (27.10), we can say ENOV is valued rather cheaply.
  • ENOV is valuated cheaply with a Price/Forward Earnings ratio of 7.28.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of ENOV indicates a rather cheap valuation: ENOV is cheaper than 98.38% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 28.06, ENOV is valued rather cheaply.
Industry RankSector Rank
PE 7.72
Fwd PE 7.28
ENOV Price Earnings VS Forward Price EarningsENOV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • 93.51% of the companies in the same industry are more expensive than ENOV, based on the Enterprise Value to EBITDA ratio.
  • Based on the Price/Free Cash Flow ratio, ENOV is valued a bit cheaper than the industry average as 70.81% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 63.99
EV/EBITDA 9.34
ENOV Per share dataENOV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • ENOV's earnings are expected to grow with 25.47% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.28
PEG (5Y)N/A
EPS Next 2Y9.23%
EPS Next 3Y25.47%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • ENOV does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ENOVIS CORP

NYSE:ENOV (2/27/2026, 8:04:00 PM)

After market: 25.47 0 (0%)

25.47

+0.05 (+0.2%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-26
Earnings (Next)05-06
Inst Owners117.36%
Inst Owner Change0.03%
Ins Owners1.14%
Ins Owner Change0.32%
Market Cap1.46B
Revenue(TTM)N/A
Net Income(TTM)-1.37B
Analysts84.44
Price Target46.36 (82.02%)
Short Float %15.5%
Short Ratio8.54
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)10.55%
Min EPS beat(2)7.76%
Max EPS beat(2)13.35%
EPS beat(4)4
Avg EPS beat(4)8.22%
Min EPS beat(4)4.97%
Max EPS beat(4)13.35%
EPS beat(8)8
Avg EPS beat(8)7.21%
EPS beat(12)12
Avg EPS beat(12)8.15%
EPS beat(16)16
Avg EPS beat(16)8.66%
Revenue beat(2)0
Avg Revenue beat(2)-0.15%
Min Revenue beat(2)-0.21%
Max Revenue beat(2)-0.09%
Revenue beat(4)0
Avg Revenue beat(4)-0.8%
Min Revenue beat(4)-1.97%
Max Revenue beat(4)-0.09%
Revenue beat(8)2
Avg Revenue beat(8)-0.81%
Revenue beat(12)4
Avg Revenue beat(12)-0.8%
Revenue beat(16)5
Avg Revenue beat(16)-4.71%
PT rev (1m)0%
PT rev (3m)-9.09%
EPS NQ rev (1m)0.92%
EPS NQ rev (3m)1.06%
EPS NY rev (1m)0.29%
EPS NY rev (3m)2.05%
Revenue NQ rev (1m)-0.14%
Revenue NQ rev (3m)-0.25%
Revenue NY rev (1m)-0.04%
Revenue NY rev (3m)0.04%
Valuation
Industry RankSector Rank
PE 7.72
Fwd PE 7.28
P/S 0.65
P/FCF 63.99
P/OCF 6.71
P/B 0.72
P/tB N/A
EV/EBITDA 9.34
EPS(TTM)3.3
EY12.96%
EPS(NY)3.5
Fwd EY13.74%
FCF(TTM)0.4
FCFY1.56%
OCF(TTM)3.8
OCFY14.9%
SpS39.05
BVpS35.33
TBVpS-8.37
PEG (NY)1.28
PEG (5Y)N/A
Graham Number51.22
Profitability
Industry RankSector Rank
ROA -30.84%
ROE -67.66%
ROCE 0.15%
ROIC 0.12%
ROICexc 0.12%
ROICexgc 0.34%
OM 0.25%
PM (TTM) N/A
GM 57.19%
FCFM 1.02%
ROA(3y)-6.18%
ROA(5y)-3.42%
ROE(3y)-11.19%
ROE(5y)-6.16%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y-45.54%
ROICexc growth 3YN/A
ROICexc growth 5Y-43.8%
OM growth 3YN/A
OM growth 5Y-43.59%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.41%
GM growth 5Y6.07%
F-Score4
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity 0.66
Debt/FCF 59.72
Debt/EBITDA 4.5
Cap/Depr 66.6%
Cap/Sales 8.7%
Interest Coverage 250
Cash Conversion 72.98%
Profit Quality N/A
Current Ratio 2.22
Quick Ratio 1.16
Altman-Z 0.76
F-Score4
WACC9.63%
ROIC/WACC0.01
Cap/Depr(3y)55.91%
Cap/Depr(5y)50.8%
Cap/Sales(3y)7.49%
Cap/Sales(5y)6.71%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)16.61%
EPS 3Y13.28%
EPS 5Y-4.57%
EPS Q2Q%-3.06%
EPS Next Y6.03%
EPS Next 2Y9.23%
EPS Next 3Y25.47%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%2.64%
Revenue Next Year4.69%
Revenue Next 2Y5.37%
Revenue Next 3Y9.39%
Revenue Next 5YN/A
EBIT growth 1Y-35.24%
EBIT growth 3YN/A
EBIT growth 5Y-48.51%
EBIT Next Year76.91%
EBIT Next 3Y28.11%
EBIT Next 5Y28.11%
FCF growth 1Y122.66%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y609.06%
OCF growth 3Y-31.69%
OCF growth 5Y-2.82%

ENOVIS CORP / ENOV FAQ

What is the ChartMill fundamental rating of ENOVIS CORP (ENOV) stock?

ChartMill assigns a fundamental rating of 4 / 10 to ENOV.


What is the valuation status of ENOVIS CORP (ENOV) stock?

ChartMill assigns a valuation rating of 8 / 10 to ENOVIS CORP (ENOV). This can be considered as Undervalued.


Can you provide the profitability details for ENOVIS CORP?

ENOVIS CORP (ENOV) has a profitability rating of 3 / 10.


What is the earnings growth outlook for ENOVIS CORP?

The Earnings per Share (EPS) of ENOVIS CORP (ENOV) is expected to grow by 6.03% in the next year.